Cold Exposure and Oral Delivery of GLP-1R Agonists by an Engineered Probiotic Yeast Strain Have Antiobesity Effects in Mice

[Image: see text] Advanced microbiome therapeutics (AMTs) holds promise in utilizing engineered microbes such as bacteria or yeasts for innovative therapeutic applications, including the in situ delivery of therapeutic peptides. Glucagon-like peptide-1 receptor agonists, such as Exendin-4, have emer...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedin, Karl Alex, Zhang, Hongbin, Kruse, Vibeke, Rees, Vanessa Emily, Bäckhed, Fredrik, Greiner, Thomas U., Vazquez-Uribe, Ruben, Sommer, Morten Otto Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661039/
https://www.ncbi.nlm.nih.gov/pubmed/37827516
http://dx.doi.org/10.1021/acssynbio.3c00455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661039/
https://www.ncbi.nlm.nih.gov/pubmed/37827516
http://dx.doi.org/10.1021/acssynbio.3c00455

Ejemplares similares